- Bullish trend confirmed on both short and long timeframes
- Lower volatility than the market (beta 0.76)
- +49.8% price growth over the last year
Weaker technical forecast for First Trust NYSE Arca Biotechnology as ETF downgraded to Hold/Accumulate
(Updated on Jul 10, 2026)
The First Trust NYSE Arca Biotechnology ETF price fell by -2.51% on the last day (Friday, 10th Jul 2026) from $256.01 to $249.59. During the last trading day the ETF fluctuated 3.06% from a day low at $248.44 to a day high of $256.04. The price has risen in 8 of the last 10 days and is up by 3% over the past 2 weeks. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -55 thousand shares and in total, 31 thousand shares were bought and sold for approximately $7.83 million.
The ETF lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 24.11% during the next 3 months and, with a 90% probability hold a price between $291.90 and $321.03 at the end of this 3-month period.
FBT Signals & Forecast
The First Trust NYSE Arca Biotechnology ETF holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the ETF giving a positive forecast for the ETF. On further gains, the ETF will meet resistance from the short-term Moving Average at approximately $253.66. On a fall, the ETF will find some support from the long-term average at approximately $231.57. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -2.58%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for First Trust NYSE Arca Biotechnology ETF
First Trust NYSE Arca Biotechnology finds support from accumulated volume at $247.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $7.61 between high and low, or 3.06%. For the last week, the ETF has had daily average volatility of 1.58%.
Our recommended stop-loss: $238.77 (-4.34%) (This ETF has medium daily movements and this gives medium risk. The RSI14 is 77 and this increases the risk substantially. There is a sell signal from a pivot top found 3 days ago.)
Trading Expectations (FBT) For The Upcoming Trading Day Of Monday 13th
For the upcoming trading day on Monday, 13th we expect First Trust NYSE Arca Biotechnology Index Fund to open at $251.36, and during the day (based on 14 day Average True Range), to move between $247.37 and $251.81, which gives a possible trading interval of +/-$4.45 (+/-1.80%) up or down from last closing price. If First Trust NYSE Arca Biotechnology Index Fund takes out the full calculated possible swing range there will be an estimated 1.80% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $247.63 (0.79%) than the resistance at $255.60 (2.41%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is First Trust NYSE Arca Biotechnology Index Fund ETF A Buy?
First Trust NYSE Arca Biotechnology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Hold candidate.
Current score:
0.932
Hold/Accumulate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 13, 2026 - $251.36 ( 0.707%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
FBT Performance
Trading levels for FBT
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 258.96 | 3.75% |
| R2 | 256.05 | 2.59% |
| R1 | 254.26 | 1.87% |
| Price | 249.59 | |
| S1 | 248.45 | -0.457% |
| S2 | 246.66 | -1.18% |
| S3 | 243.75 | -2.34% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 256.19 | 2.64% |
| R2 | 256.01 | 2.57% |
| R1 | 255.60 | 2.41% |
| Price | 249.59 | |
| S1 | 247.63 | -0.785% |
| S2 | 246.96 | -1.05% |
| S3 | 200.65 | -19.61% |
FBT Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 12, 2024 | Dec 13, 2024 | Dec 31, 2024 | $1.17 | 0.705% |
| 2 | Dec 22, 2021 | Dec 30, 2021 | Jan 10, 2022 | $2.21 | 1.44% |
| 3 | Sep 22, 2015 | Sep 23, 2015 | Sep 30, 2015 | $0.0200 | 0.0197% |
| 4 | Jun 24, 2015 | Jun 24, 2015 | Jun 30, 2015 | $0.0650 | 0.0524% |
| 5 | Mar 25, 2015 | Mar 25, 2015 | Mar 31, 2015 | $0.0480 | 0.0406% |
FAQ
Click here for our free guide on how to buy First Trust NYSE Arca Biotechnology Index Fund ETF.
Buy FBT